Thus, many of the featured studies seek to overcome ... Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), told The American Journal of Managed Care ® in an interview ...

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression. Emotional barriers patients face when communicating with their ...

“With FDA approval due in 2019, it appears that Keytruda/Inlyta will and should become a new standard of care for the renal cancer patient population after posting this trial data.” The combo ...

Gain practical insights into overcoming operational hurdles, optimizing assay selection, and aligning with regulatory expectations to drive progress in oncology therapeutics. Download the full ...